BOEHRINGER INGELHEIM LIMITED
Company Information
- Company Number
- 00711858
- Registered Address
- Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
- Status
- Active
- Employee Count
- 348
- Turnover
- £314,669,000
- EBITDA
- £10,164,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 1 January 1962
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2024 - 31 Dec 2024 | 29 Jan 2025 | 24 | 83% | 16% | 1% | 14% |
| 01 Jan 2024 - 30 Jun 2024 | 29 Jul 2024 | 20 | 85% | 14% | 1% | 1% |
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 18 | 83% | 16% | 1% | 23% |
| 01 Jan 2022 - 30 Jun 2022 | 14 Jul 2022 | 24 | 77% | 22% | 1% | 20% |
| 01 Jul 2021 - 31 Dec 2021 | 28 Jan 2022 | 24 | 77% | 22% | 1% | 20% |
| 01 Jan 2021 - 30 Jun 2021 | 28 Jul 2021 | 24 | 77% | 21% | 2% | 35% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 34 | 54% | 43% | 3% | 28% |
| 01 Jan 2019 - 30 Jun 2019 | 19 Jul 2019 | 31 | 62% | 32% | 6% | 37% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 41 | 26% | 52% | 22% | 31% |
| 01 Jan 2018 - 30 Jun 2018 | 29 Jul 2018 | 40 | 35% | 48% | 17% | 37% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
https://www.boehringer-ingelheim.com/uk/bipdf/potermsandconditionsv12dec2018pdf Standard terms are 60 days
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
Dispute Resolution Process
Boehringer Ingelheim has an Accounts Payable shared service centre based in Poland which can be contacted by email or by using a local UK telephone number.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
Boehringer Ingelheim Limited is a multinational pharmaceutical company that operates in the UK. It was founded in 1885 and is now headquartered in Bracknell, Berkshire. The company is committed to sustainability and has implemented various initiatives to reduce its environmental impact and promote social responsibility.
The company's sustainability program focuses on five key areas: reducing carbon emissions, conserving natural resources, promoting animal welfare, supporting local communities, and ensuring ethical business practices. Boehringer Ingelheim Limited has also set ambitious targets to become carbon-neutral by 2025 and to achieve zero waste to landfill by 2022.
As a pharmaceutical company, Boehringer Ingelheim Limited offers a wide range of products and services in the areas of human pharmaceuticals, animal health, and biopharmaceuticals. Its products include treatments for respiratory diseases, cardiovascular diseases, and diabetes, as well as vaccines for livestock and pets.
The key people at Boehringer Ingelheim Limited include Hubertus von Baumbach, the Chairman of the Board of Managing Directors, and Michael Schmelmer, the Chief Financial Officer. The company has over 10,000 employees in the UK and is also committed to providing a safe and inclusive workplace for its employees.
For more information about Boehringer Ingelheim Limited and its sustainability efforts, customers can visit their website at www.boehringer-ingelheim.co.uk. The registered office address is Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS, UK.
